VERA
Vera Therapeutics, Inc. Class A Common StockstockNASDAQ
Market OpenNov 19, 2026 3:00:10 PM EST
26.50USD+3.597%(+0.92)601,510
Loading…
Loading…
1.92B
Healthcare
Biotechnology
HQ
Brisbane, CA, USA
Previous Close
$25.58
Beta
1.25
52-Week High
$56.05 2025-12-24
52-Week Low
$25.34 2026-11-18
SMA 50
$30.58
SMA 200
$35.87
Avg. Vol 10D
1.36M
Avg. Vol 30D
1.52M
Avg. Vol 90D
1.97M
Relative Vol
0.40
72.30M
52.62M
72.79%
12,141,556
20.75%
8.47
54%/46%
64.02%
49.38%
0.4300%
1,800,000
7
734
4,630
-415.3M
-5.91
-376.0M
-113.46
Nov 17, 2026
Vera Therapeutics stock hits 52-week low at 26.32 USD ·
Investing.com
Nov 10, 2026
Nov 7, 2026
Nov 6, 2026
VERA Profile
trucode gene repair is advancing its novel triplex gene editing platform to potentially cure devastating genetic diseases, with initial focus on sickle cell disease and cystic fibrosis. the elegance of triplex gene editing lies in its ability to harness natural, high-fidelity dna repair mechanisms, and its independence from the requirement for exogenous nucleases and viral vectors.
VERA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 29.04 | 2026-11-12 | -8.57% | 0.755 |
| 1M | 28.92 | 2026-10-19 | -8.20% | 1.752 |
| 3M | 32.28 | 2026-08-19 | -17.74% | 1.777 |
| 6M | 33.25 | 2026-05-19 | -20.15% | 1.085 |
| 1Y | 28.55 | 2025-11-19 | -7.01% | 1.255 |
| 2Y | 45.90 | 2024-11-19 | -42.16% | — |
| 5Y | 31.20 | 2021-11-19 | -14.90% | 1.076 |
VERA Stock Summary
Vera Therapeutics, Inc. Class A Common Stock (NASDAQ:VERA) stock price today is $26.55, and today's volume is 599,841. VERA is up 3.791% today. The 30 day average volume is 1.52M. VERA market cap is $1.92B with 72.30M shares outstanding.